Doctors are increasingly alarmed that a type of dementia which closely resembles Alzheimer's may have resulted in the ...

First Patient Expected to be Dosed Next Week with Intranasal ForalumabPET Scan Shows Presence of Untreated Neuroinflammation ...

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

The UCLA team studied health records from over 97,000 patients. Their AI tool looked at patterns in things like age, ...

Patients with diabetes undergoing hemodialysis who initiate GLP-1 agonists have an 18% lower risk for incident dementia than ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...